Tactile Systems (TCMD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 7, 2025, to address director elections, auditor ratification, executive compensation, and a new equity incentive plan.
Proxy materials are available online, with options for electronic or paper delivery to reduce environmental impact and costs.
Forward-looking statements are included, with risks detailed in the annual report.
Voting matters and shareholder proposals
Shareholders will vote to elect eight directors, ratify Grant Thornton LLP as auditor, approve executive compensation, determine frequency of say-on-pay votes, and approve the 2025 Equity Incentive Plan.
Board recommends voting FOR all proposals and for an annual say-on-pay vote.
Board of directors and corporate governance
Board consists of eight nominees, with 7 of 8 being independent and diverse in skills and backgrounds.
Board committees are fully independent, with an independent chairman and annual elections for all directors.
Board oversight includes ESG, risk management, and annual evaluations, with no supermajority voting or poison pill provisions.
Stockholders can communicate with the board and nominate directors following established procedures.
Latest events from Tactile Systems
- Proxy seeks approval for director elections, auditor, executive pay, and governance amendment.TCMD
Proxy Filing10 Mar 2026 - Double-digit revenue and margin growth in 2025, with 2026 guidance for continued expansion.TCMD
Q4 202517 Feb 2026 - Q2 revenue up 7%, net income $4.3M, guidance trimmed, margins and innovation strong.TCMD
Q2 20242 Feb 2026 - Strong growth, new products, and tech investments position for accelerated expansion in 2025.TCMD
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 revenue up 5%, gross margin expands, net income down, $30M buyback program authorized.TCMD
Q3 202417 Jan 2026 - New product launches and policy shifts position the business for growth and operational efficiency in 2025.TCMD
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - Strong growth and innovation position the business to lead in a $10B underpenetrated market.TCMD
Oppenheimer 35th Annual Health Care MedTech and Services Conference26 Dec 2025 - Strategic execution and innovation drive double-digit growth and market leadership in core segments.TCMD
Piper Sandler 37th Annual Healthcare Conference2 Dec 2025 - Q4 revenue up 10.2%, improved margins, and 2025 guidance targets 8–10% growth.TCMD
Q4 20242 Dec 2025